These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6891841

  • 1. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.
    Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G.
    Thromb Haemost; 1982 Dec 27; 48(3):266-9. PubMed ID: 6891841
    [Abstract] [Full Text] [Related]

  • 2. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ, Kingston IB, Anderson S.
    Anal Biochem; 1995 Apr 10; 226(2):225-31. PubMed ID: 7793622
    [Abstract] [Full Text] [Related]

  • 3. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K, Thorsen S.
    Thromb Haemost; 2000 Aug 10; 84(2):299-306. PubMed ID: 10959704
    [Abstract] [Full Text] [Related]

  • 4. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 10; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 5. Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay.
    Rijken DC, Juhan-Vague I, Collen D.
    J Lab Clin Med; 1983 Feb 10; 101(2):285-94. PubMed ID: 6681624
    [Abstract] [Full Text] [Related]

  • 6. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
    Wiman B, Rånby M.
    Thromb Haemost; 1986 Apr 30; 55(2):189-93. PubMed ID: 3087001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY, Clark AS, Littlefield BA.
    Biochem Biophys Res Commun; 1987 Jan 15; 142(1):147-54. PubMed ID: 3101684
    [Abstract] [Full Text] [Related]

  • 13. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR, Soria J, Soria C, Collen D, Caen JP.
    Thromb Haemost; 1984 Feb 28; 51(1):108-9. PubMed ID: 6539000
    [Abstract] [Full Text] [Related]

  • 14. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 20. Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time model.
    Mellott MJ, Ramjit DR, Stabilito II, Hare TR, Senderak ET, Lynch JJ, Gardell SJ.
    Thromb Haemost; 1995 Mar 30; 73(3):478-83. PubMed ID: 7545321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.